Global X Robo Global Robotics & Automation ETF vs Tenet Healthcare Corporation — how do they compare? Global X Robo Global Robotics & Automation ETF trades at $81.26 (market cap $2.06B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 10.2× Global X Robo Global Robotics & Automation ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Global X Robo Global Robotics & Automation ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Robo Global Robotics & Automation ETF for 36 Days and Tenet Healthcare Corporation for 15 Days on average.
| ROBO | THC | |
|---|---|---|
Market Cap | $2.06B | $20.98B |
Volume | 148,111 | 428,008 |
Sector | Sector/Thematic | Health |
52-Week High | $90.34 | $280.77 |
52-Week Low | $63.04 | $161.37 |
Typical Hold Time | 36 Days | 15 Days |
Enterprise Value | — | $32.06B |
Signals from Pluang's Aura AI — not financial advice
ROBO trades at $81.26, down 0.68% on the day, with a bullish technical signal from moving averages but bearish oscillators. The stock shows strong institutional interest in robotics and AI themes, with recent news highlighting accelerating adoption across manufacturing, healthcare, and military applications. Financial ratios are unavailable in the current dataset.
The robotics sector offers long-term growth potential amid labor shortages and AI integration, though high RSI levels suggest near-term overbought conditions. Key risks include valuation concerns and sector competition, while analyst coverage remains favorable for diversified robotics exposure.
Tenet Healthcare (THC) trades at $260.57, showing modest daily gains of 0.28% with strong technical support at $257 and resistance at $262. The stock demonstrates robust fundamentals with a P/E of 10.07, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights the upcoming Q3 2026 earnings release on October 29, 2026, while the company maintains strong cash flow generation of $3.54 billion from operations.
THC presents a compelling investment case with 81% analyst buy ratings and a $283.36 consensus price target representing 8.7% upside potential. The company's expanding capital return strategy and projected revenue growth to $22.6 billion in 2026 support bullish sentiment, though investors should monitor surgical volume trends and capital allocation sustainability as key risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →